BSF Capital sets target for Dr. Sulaiman Al Habib stock

Dr. Sulaiman Al Habib Medical Services stock has a new SAR 240.00 target from BSF Capital, which assigned a Hold rating on September 20, 2026. The target places the analyst view above the company's latest quoted Tadawul level, while the group continues expanding its healthcare footprint.

Three dated operating milestones

On September 17, 2026, Dr. Sulaiman Al Habib Medical Services Group began operating the Red Sea Hospital under its strategic partnership with Red Sea Global. The facility has 44 beds, 41 outpatient clinics and nine intensive care and neonatal care beds, according to Saudi Press Agency.

On September 20, 2026, BSF Capital rated the shares Hold and set a SAR 240.00 target, as Argaam reported. The target is a concrete valuation reference for investors because it combines a named rating with a stated price level rather than a broad sector view.

In the first half of 2026, the group earned SAR 1.16 billion, including SAR 662.7 million in the second quarter, according to Argaam. The half-year figure gives the analyst target an operating backdrop: earnings growth is being assessed alongside hospital capacity and expansion, not as a standalone chart signal.

What does the target imply?

BSF Capital's SAR 240.00 target is above the SAR 228.50 Tadawul reference reported on October 6, 2026, but the currencies and venues differ from the euro perspective used for this article. The comparison is therefore directional context, not a combined daily performance figure.

The Red Sea opening adds a tangible operating milestone to the valuation discussion. Its 44 beds and 41 outpatient clinics show the type of capacity addition that can support future activity, although the available announcement does not quantify its expected revenue or profit contribution.

Market value and listing context

Dr. Sulaiman Al Habib Medical Services Group had a market capitalization of SAR 79.9 billion on October 8, 2026. The company is listed on Tadawul under ticker 4013, and its latest structured market quote was SAR 228.40, up SAR 0.30, or 0.13 percent, from SAR 228.10 on October 8, 2026.

The combination of a Hold rating, a SAR 240.00 target and first-half net profit of SAR 1.16 billion frames the stock around execution and valuation. The hospital opening supplies a dated expansion milestone, while the reported earnings provide the more immediate measure of operating scale.

More news and analyses on Dr. Sulaiman Al Habib Medical Services stock